Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion re-launched the leveraged pharmaceutical ETF, the Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL), which has a 1.12% net expense ratio. “The pharmaceutical sector is continuously evolving, with research and development [...] Read more on ETFtrends.com >
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Retirement savings play a crucial role in securing financial stability in your golden years. For those aiming high, being in the top 3% of retirees in terms of savings enhances comfort and offers greater financial freedom. Using data from the Federal Reserve's Survey of Consumer Finances, a 2024 survey by the Employee Benefit Research Institute, reveals that individuals with over $1 million in retirement accounts rank in the top 3% of retirees. Only 3.2% of retirees have surpassed the $1 million
The $50 million purchase could turn into Nvidia's biggest investment.
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
These proven wealth builders could be exactly what you're searching for right now.
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
These three tech stocks look like reliable long-term winners.
The number probably isn't anywhere near what you think it is.
You'll get dividends and more with these great stocks.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.